Allogeneic CAR Gamma-Delta T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic CAR Gamma-Delta T Cells, covering 2024-12-03 to 2024-12-03. Get the full timeline:
Most recent: Clinical Trial Update: A Safety and Efficacy Study of Allogeneic CAR Gamma-Delta T Cells in Subjects with Relapsed/Refractory Solid Tumors [Phase 1, Phase 2]